SCHEMBL3949288

SCHEMBL3949288

Cc1nccn1-c1cc(NC(=O)c2ccc(Nc3nccc(-n4ccnc4)n3)cc2)cc(C(F)(F)F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 3/20 0.52
▸ ABL1 P00519 10/20 0.48
▸ BCR P11274 4/20 0.48
▸ KDR P35968 3/20 0.48
▸ ADORA3 P0DMS8 2/20 0.48
▸ NR1I2 O75469 1/20 0.48
▸ PTGS1 P23219 1/20 0.48
▸ CHRNA4 P43681 1/20 0.48
▸ PDE3A Q14432 1/20 0.48
▸ KIT P10721 3/20 0.48
▸ BRAF P15056 3/20 0.48
▸ LYN P07948 2/20 0.48
▸ LDLR P01130 2/20 0.48
▸ PDGFRB P09619 2/20 0.48
▸ PCSK9 Q8NBP7 2/20 0.48
▸ TEK Q02763 2/20 0.48
▸ RAF1 P04049 2/20 0.48
▸ EPHB6 O15197 1/20 0.48
▸ CA12 O43570 1/20 0.48
▸ CACNA1F O60840 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3949137 0.92 CSF1R (0.56) CSF1RABL1BCRKDRADORA3
SCHEMBL4176681 0.92 CSF1R (0.60) CSF1RABL1BCRKDRADORA3
SCHEMBL4162541 0.91 NR2E1 (0.57) CSF1RABL1BCRKDRADORA3
SCHEMBL3952869 0.87 ABL1 (0.63) CSF1RABL1BCRKDRADORA3
SCHEMBL3949782 0.86 NR2E1 (0.61) CSF1RABL1BCRKDRADORA3
SCHEMBL3953249 0.84 ABL1 (0.63) CSF1RABL1BCRKDRADORA3
SCHEMBL3954694 0.83 ABL1 (0.63) CSF1RABL1BCRADORA3KIT
SCHEMBL3952991 0.83 ABL1 (0.68) CSF1RABL1BCRKDRADORA3
SCHEMBL3945325 0.82 CSF1R (0.52) CSF1RABL1BCRKDRADORA3
SCHEMBL3947709 0.82 CSF1R (0.66) CSF1RABL1BCRKDRADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1922309-B1 N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF IL YANG PHARM CO LTD (KR) 2014-05-21 — — EP disclosed
US-7501424-B2 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof IL-YANG PHARM. CO., LTD. (KR) 2009-03-10 — — US disclosed
US-20080096899-A1 N-Phenyl-2-Pyrimidine-Amine Derivatives and Process for the Preparation Thereof IL-YANG PHARM. CO., LTD. (KR) 2008-04-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096899-A1 N-Phenyl-2-Pyrimidine-Amine Derivatives and Process for the Preparation Thereof ITPA, TYMP, THPO CSF1R 1031/4885ABL1 451/4885BCR 990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback